Adverum Biotechnologies Presents Long-term Data through March 10, 2021 from the OPTIC Trial of…
-- Long-term durability and maintained efficacy; sustained robust aflibercept protein expression observed -- -- 60% of patients injection free beyond 1 year following 2 x 10^11 single dose -- REDWOOD CITY, Calif., May 01, 2021…